153 related articles for article (PubMed ID: 6494827)
21. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.
Wymenga LF; Boomsma JH; Groenier K; Piers DA; Mensink HJ
BJU Int; 2001 Aug; 88(3):226-30. PubMed ID: 11488734
[TBL] [Abstract][Full Text] [Related]
22. [Phosphatases and bone scan in prostatic cancer].
Urrutia M; Montero J; Grade J; Llopis M
Actas Urol Esp; 1977; 1(4):207-12. PubMed ID: 567001
[No Abstract] [Full Text] [Related]
23. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
[TBL] [Abstract][Full Text] [Related]
24. [Relation between serum PAP (prostate acid phosphatase) and bone scintigraphy in prostatic cancer].
Aizawa T; Itoh T; Tsujino S; Namiki K; Miki M
Kaku Igaku; 1992 Nov; 29(11):1277-83. PubMed ID: 1484418
[TBL] [Abstract][Full Text] [Related]
25. [Correlation and development of the enzyme activity of phosphatases and the gammagraphic distribution of bone deposits in prostatic cancer (preliminary study)].
Maganto Pavón E; Mateos Torres JA; Verdú Tartajo F; Boronat Tormo F; Mayayo Dehesa T; Romero Aguirre C
Actas Urol Esp; 1981; 5(2):93-8. PubMed ID: 7270286
[No Abstract] [Full Text] [Related]
26. Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
Barichello M; Gion M; Bonazza A; Delli Ponti US; Bolgan A; Contemori GP; Barioli P; Capitanio G; Pecori B; Omacini S
Eur Urol; 1995; 27(4):295-300. PubMed ID: 7544735
[TBL] [Abstract][Full Text] [Related]
27. Serum osteocalcin concentration in patients with prostatic cancer.
Francini G; Bigazzi S; Leone V; Gennari C
Am J Clin Oncol; 1988; 11 Suppl 2():S83-7. PubMed ID: 3266542
[TBL] [Abstract][Full Text] [Related]
28. [Comparative study between acid phosphatases and bone gammagraphy in cancer of the prostate].
González Martín M; Lancina Martín A; Chantada Abal V; Lamas Meilán AC; Miguez Codesido M; Serrano Barrientos J
Actas Urol Esp; 1985; 9(1):83-8. PubMed ID: 4013851
[No Abstract] [Full Text] [Related]
29. [Tumor markers in cancer of the prostate].
Nogueira March JL; Ojea A; Jamardo D; Figueiredo L; Diez E; Pérez Villanueva J
Actas Urol Esp; 1985; 9(1):79-82. PubMed ID: 4013850
[No Abstract] [Full Text] [Related]
30. Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.
Killian CS; Emrich LJ; Vargas FP; Yang N; Wang MC; Priore RL; Murphy GP; Chu TM
J Natl Cancer Inst; 1986 Feb; 76(2):179-85. PubMed ID: 2418245
[TBL] [Abstract][Full Text] [Related]
31. Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
Fincker F; Sauvan R; Pasquier J
Am J Clin Oncol; 1988; 11 Suppl 2():S68-70. PubMed ID: 2468277
[TBL] [Abstract][Full Text] [Related]
32. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
Casetta G; Gamba P; Piana P; Pecchio F; Tizzani A
Minerva Urol Nefrol; 1995 Mar; 47(1):9-12. PubMed ID: 7570264
[TBL] [Abstract][Full Text] [Related]
33. Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
Mackintosh J; Simes J; Raghavan D; Pearson B
Br J Urol; 1990 Jul; 66(1):88-93. PubMed ID: 2203503
[TBL] [Abstract][Full Text] [Related]
34. [Bone scintigraphy for diagnosis of bone metastasis in patients with prostatic cancer].
Nakashima J
Nihon Rinsho; 2002 Dec; 60 Suppl 11():135-9. PubMed ID: 12599559
[No Abstract] [Full Text] [Related]
35. The role of bone scanning in the assessment of prostatic carcinoma.
McGregor B; Tulloch AG; Quinlan MF; Lovegrove F
Br J Urol; 1978 May; 50(3):178-81. PubMed ID: 753456
[TBL] [Abstract][Full Text] [Related]
36. [The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Furukawa Y; Tanaka H
Kaku Igaku; 1994 Jun; 31(6):541-50. PubMed ID: 7520953
[TBL] [Abstract][Full Text] [Related]
37. Plasma acid and alkaline phosphatase in patients with breast cancer.
Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
[TBL] [Abstract][Full Text] [Related]
38. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
Wang ZL; Wang XF
Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960
[TBL] [Abstract][Full Text] [Related]
39. Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
Reikerås O; Due J; Sundsfjord JA
Int Urol Nephrol; 1988; 20(1):51-4. PubMed ID: 3283071
[TBL] [Abstract][Full Text] [Related]
40. A reappraisal of serial isotope bone scans in prostate cancer.
O'Donoghue JM; Rogers E; Grimes H; McCarthy P; Corcoran M; Bredin H; Given HF
Br J Radiol; 1993 Aug; 66(788):672-6. PubMed ID: 7536607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
